The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDairy Crest Regulatory News (DCG)

  • There is currently no data for DCG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

31 Jan 2018 07:00

RNS Number : 3968D
Dairy Crest Group PLC
31 January 2018
 

 

31 January 2018

 

Dairy Crest Group plc ("Dairy Crest")

 

Trading Update

 

Dairy Crest is today issuing a Trading Update for the nine months ended 31 December 2017.

 

The outlook for the full year remains in line with our expectations.

 

Total revenue for the Group was well ahead of last year for the nine month period. This was driven by a combined strong performance from the company's key brands, Cathedral City, Clover, Country Life and Frylight. Together, they delivered revenue growth of 7% for the first nine months of the year.

 

Cathedral City has delivered another good quarter. We recently launched a fresh TV sponsorship campaign and Cathedral City Spreadable won 'Product of the Year 2018' in the UK cheese category of the world's largest consumer survey award for product innovation.

 

All of Dairy Crest's spreads brands - Clover, Utterly Butterly, Vitalite and Willow - continued to gain market share. Growth in Frylight remains strong going into the fourth quarter driven by a significant increase in the number of distribution points across the UK. Country Life volumes continued to come under pressure from the considerable increase in the cost of cream over the last year. The cream price has fallen in recent months and Country Life promotional activity will pick up in 2018.

 

Sales of our functional ingredients - demineralised whey powder and galacto-oligosaccharide ('GOS'), both used in the growing global infant formula market - are progressing well. We continue to research uses of GOS beyond the infant formula market.

 

 

Mark Allen, Chief Executive of Dairy Crest, commented:

"We have seen strong growth across our key brands, with Cathedral City, Clover and Frylight performing well and all of our spreads brands increasing market share. I am delighted that Cathedral City Spreadable, one of our more recent innovations, was voted 'Product of the Year 2018' in the cheese category by consumers.

 

"We continue to build the customer base for our functional ingredients business and we will talk in greater detail about this in May."

 

 

 

Dairy Crest will issue its Preliminary Results for the year ended 31 March 2018 on 23 May 2018.

 

For further information:

Investors/Analysts

Tom Atherton

Dairy Crest

01372 472264

Kate Goode

Dairy Crest

01372 472236

Media

Tim Danaher/Alison Kay

Brunswick

020 7404 5959

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTURVBRWAAAOAR
Date   Source Headline
22nd Feb 20192:11 pmRNSForm 8.3 - Dairy Crest Group plc
22nd Feb 201911:51 amGNWDimensional Fund Advisors Ltd. : Form 8.3 - [Insert name of offeree or offeror]
22nd Feb 201911:10 amPRNForm 8 (OPD) - Dairy Crest Group Plc
22nd Feb 201910:40 amRNSForm 8.3 - Dairy Crest Group Plc
22nd Feb 20197:14 amRNSRecommended Cash Acquisition of Dairy Crest plc
5th Feb 201910:25 amRNSPCA Dealing
1st Feb 20192:43 pmRNSDirector/PDMR Shareholding
31st Jan 20199:58 amRNSTotal Voting Rights
31st Jan 20197:00 amRNSTrading Statement
7th Jan 20193:44 pmRNSDirector / PDMR Shareholding
2nd Jan 20199:47 amRNSTotal Voting Rights
30th Nov 201811:01 amRNSTotal Voting Rights & Capital
7th Nov 20189:09 amRNSCorrection: Interim results
7th Nov 20187:00 amRNSInterim Results
2nd Nov 201811:21 amRNSNotification of Major Holdings
2nd Nov 201811:20 amRNSNotification of Major Holdings
31st Oct 201810:37 amRNSTotal Voting Rights & Capital
17th Oct 20183:35 pmRNSStandard form for notification of major holdings
11th Oct 20182:20 pmRNSStandard form for notification of major holdings
28th Sep 201812:34 pmRNSTotal Voting Rights & Capital
18th Sep 201810:27 amRNSDirector/PDMR Shareholding
17th Sep 20187:00 amRNSTrading Update
31st Aug 20187:00 amRNSTotal Voting Rights & Capital
20th Aug 20183:26 pmRNSDirector/PDMR Shareholding
13th Aug 20185:15 pmRNSDirector / PDMR Shareholding
6th Aug 20184:43 pmRNSDirector / PDMR Shareholding
31st Jul 201812:04 pmRNSTotal Voting Rights & Capital
18th Jul 20189:54 amRNSResult of AGM
17th Jul 20187:00 amRNSAGM and Trading Update
12th Jul 201811:54 amRNSBlock listing application
6th Jul 20185:01 pmRNSDirector/PDMR Shareholding
29th Jun 201812:56 pmRNSTotal Voting Rights & Capital
28th Jun 201810:18 amRNSDirector Dealing
21st Jun 201810:09 amRNSDirector and PCA Dealing
20th Jun 20182:05 pmRNSBlock listing Interim Review
19th Jun 201811:57 amRNSTR-1: Notification of major holdings
15th Jun 20185:30 pmRNS2018 Annual Report and Accounts and Notice of AGM
8th Jun 201812:39 pmRNSDirector and PCA Dealing
1st Jun 20189:49 amRNSTotal Voting Rights & Capital
31st May 201810:38 amRNSDirector / PDMR Shareholding
23rd May 201810:01 amRNSRESULT OF PLACING OF NEW ORDINARY SHARES
23rd May 20187:01 amRNSPROPOSED PLACING OF NEW ORDINARY SHARES
23rd May 20187:00 amRNSPreliminary Results
10th May 20184:08 pmRNSBlock Listing Application
10th May 20182:33 pmRNSNon-executive Director Appointment
30th Apr 20181:47 pmRNSTotal Voting Rights & Capital
29th Mar 20182:09 pmRNSTotal Voting Rights & Capital
28th Feb 201811:19 amRNSTotal Voting Rights & Capital
16th Feb 20185:10 pmRNSDirector/PDMR Shareholding
9th Feb 201812:24 pmRNSNotification of Major Holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.